Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Conference preview: ChinaBio Partnering Forum 2019
Asia
The 11th annual ChinaBio Partnering Forum global life science partnering event, which will be held on May 8 and 9 in Shanghai, China, is expected to attract more than 1,400 executives from 500-plus life sciences companies spanning an estimated 25 countries.   7 May 2019
NHS partners with drugmakers to eliminate hep C
Big Pharma
The National Health Service, the UK’s government-run health system, has partnered with Gilead Sciences, Merck Sharp and Dohme and AbbVie to help eliminate hepatitis C in England.   3 May 2019
Clint Eastwood’s patent lawsuit dismissed
Biotechnology
A judge has dismissed actor Clint Eastwood’s motion to gain ownership over two diabetes patents currently assigned to Molecular Defenses Corporation.   2 May 2019
Big Pharma
AstraZeneca has begun collaborating with UK-headquartered artificial intelligence company BenevolentAI to use AI and machine learning for the discovery and development of new treatments.   2 May 2019
Big Pharma
Amgen and Roche have filed a joint patent infringement claim against Samsung’s biopharmaceutical company Bioepis.   1 May 2019
Big Pharma
A division of Novartis has entered into an agreement with Taiwan-based EirGenix to market a medicine which treats some cancer tumours.   1 May 2019
Asia
PepsiCo India is attempting to settle a lawsuit against four Indian farmers who the food and drink company say infringed its IP by growing a protected variety of potato.   30 April 2019
Americas
The US Court of Appeals for the Federal Circuit has rejected Medtronic’s attempt to revisit a ruling that lumbered the medical device company with a $23 million loss.   30 April 2019
Americas
The US Court of Appeals for the Federal Circuit affirmed a series of Patent Trial and Appeal Board inter partes reviews, which upheld a patent owned by Eli Lilly late last week.   29 April 2019
Americas
The six antitrust class-action lawsuits that have been brought against AbbVie could result in more scrutiny of settlement agreements between the innovator and the biosimilar manufacturer, with potential antitrust complications.   29 April 2019